Halozyme Therapeutics, Inc. financial data

Symbol
HALO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
12390 El Camino Real, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
GLOBAL YACHT SERVICES INC (to 3/12/2004)
Latest financial report
Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 768 % +16.3%
Quick Ratio 121 % +16.9%
Debt-to-equity 663 % -36.2%
Return On Equity 156 % -2.08%
Return On Assets 20.5 % +46.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 127M shares -3.69%
Common Stock, Shares, Outstanding 127M shares -3.71%
Entity Public Float 3.5B USD -31.4%
Common Stock, Value, Issued 127K USD -3.79%
Weighted Average Number of Shares Outstanding, Basic 127M shares -3.88%
Weighted Average Number of Shares Outstanding, Diluted 130M shares -2.95%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 947M USD +21.3%
Research and Development Expense 79.9M USD +3.03%
Costs and Expenses 470M USD +0.15%
Operating Income (Loss) 477M USD +53.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 480M USD +51%
Income Tax Expense (Benefit) 87.6M USD +36.8%
Net Income (Loss) Attributable to Parent 392M USD +54.6%
Earnings Per Share, Basic 3.07 USD/shares +60.7%
Earnings Per Share, Diluted 3.01 USD/shares +61%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 154M USD -43.7%
Accounts Receivable, after Allowance for Credit Loss, Current 273M USD +27.6%
Inventory, Net 131M USD +1.93%
Assets, Current 1.13B USD +28.2%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 40M USD +6.7%
Operating Lease, Right-of-Use Asset 34.5M USD -7.23%
Intangible Assets, Net (Excluding Goodwill) 420M USD -14.5%
Goodwill 417M USD 0%
Assets 2.12B USD +11.9%
Accounts Payable, Current 12.4M USD -35.8%
Employee-related Liabilities, Current 17.4M USD -12.9%
Accrued Liabilities, Current 96.4M USD +1.28%
Contract with Customer, Liability, Current 667K USD
Liabilities, Current 109M USD -5.53%
Contract with Customer, Liability, Noncurrent 2.25M USD
Deferred Income Tax Liabilities, Net 12M USD
Other Liabilities, Noncurrent 40.4M USD +42.2%
Liabilities 1.67B USD +1.33%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.94M USD -666%
Retained Earnings (Accumulated Deficit) 398M USD +78.9%
Stockholders' Equity Attributable to Parent 453M USD +81.7%
Liabilities and Equity 2.12B USD +11.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 129M USD +48.8%
Net Cash Provided by (Used in) Financing Activities -489K USD +99.7%
Net Cash Provided by (Used in) Investing Activities -82.7M USD -37.4%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 127M shares -3.71%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 46.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 154M USD -43.7%
Deferred Tax Assets, Valuation Allowance 2.59M USD +266%
Deferred Tax Assets, Gross 123M USD -28.7%
Operating Lease, Liability 30.8M USD -4.95%
Payments to Acquire Property, Plant, and Equipment 3.55M USD -68.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 384M USD +49.6%
Lessee, Operating Lease, Liability, to be Paid 40.7M USD -13.4%
Property, Plant and Equipment, Gross 63.8M USD +14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.03M USD -2.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.58M USD -15.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.51M USD -30.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.68M USD +3.88%
Deferred Tax Assets, Operating Loss Carryforwards 32.8M USD -0.41%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 21.9M USD +12.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.3M USD +2.86%
Operating Lease, Payments 6.8M USD +4.62%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 71M USD +17.3%
Depreciation, Depletion and Amortization 10.6M USD -1.24%
Deferred Tax Assets, Net of Valuation Allowance 120M USD -29.9%
Share-based Payment Arrangement, Expense 41.6M USD +21.7%
Interest Expense 18.7M USD -5.09%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%